No human virus sequences detected by next-generation sequencing in benign verrucous skin tumors occurring in BRAF-inhibitor-treated patients

Experimental Dermatology

Volumn 22, Issue 11, 2013, Pages 725-729

  Ganzenmueller, Tina ^a   Hage, Elias ^a   Yakushko, Yuri ^a   Kluba, Jeanette ^a   Woltemate, Sabrina ^a   Schacht, Vivien ^a   Schulz, Thomas F ^a   Gutzmer, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

BRAF inhibitors; Cutaneous side effects; Next generation sequencing; Verrucous keratosis; Virus

Indexed keywords

B RAF KINASE; VEMURAFENIB;

ADULT; AGED; ARTICLE; B RAF KINASE INHIBITOR ASSOCIATED VERRUCOUS KERATOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; KERATOSIS; MALE; MICROBIOME; NON MELANOMA SKIN CANCER; VIRUS ETIOLOGY; WART VIRUS;

BRAF INHIBITORS; CUTANEOUS SIDE EFFECTS; NEXT-GENERATION SEQUENCING; VERRUCOUS KERATOSIS; VIRUS;

ADULT; AGED; BIOPSY; CARCINOMA, VERRUCOUS; CELL PROLIFERATION; DNA, VIRAL; FEMALE; GENE LIBRARY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDOLES; KERATINOCYTES; MALE; MELANOMA; MIDDLE AGED; MUTATION; PAPILLOMAVIRIDAE; PROTO-ONCOGENE PROTEINS B-RAF; SKIN NEOPLASMS; SULFONAMIDES;

EID: 84886793656     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12249     Document Type: Article

References (41)

1. Sullivan R J, Flaherty K. Oncogene 2013: 32: 2373-2379.
2. Flaherty K T, McArthur G. Cancer 2010: 116: 4902-4913.
3. Puig-Butille J A, Badenas C, Ogbah Z et al. Exp Dermatol 2013: 22: 148-150.
4. Chapman P B, Hauschild A, Robert C et al. N Engl J Med 2011: 364: 2507-2516.
5. Sosman J A, Kim K B, Schuchter L et al. N Engl J Med 2012: 366: 707-714.
6. Flaherty K T, Puzanov I, Kim K B et al. N Engl J Med 2010: 363: 809-819.
7. Gutzmer R, Wollenberg A, Ugurel S et al. Dtsch Arztebl Int 2012: 109: 133-140.
8. Chu E Y, Wanat K A, Miller C J et al. J Am Acad Dermatol 2012: 67: 1265-1272.
9. Harvey N T, Millward M, Wood B A. Am J Dermatopathol 2012: 34: 822-826.
10. Anforth R M, Blumetti T C, Kefford R F et al. Br J Dermatol 2012: 167: 1153-1160.
11. Boussemart L, Routier E, Mateus C et al. Ann Oncol 2013: 24: 1691-1697.
12. Rinderknecht J D, Goldinger S M, Rozati S et al. PLoS ONE 2013: 8: e58721.
13. Su F, Viros A, Milagre C et al. N Engl J Med 2012: 366: 207-215.
14. Oberholzer P A, Kee D, Dziunycz P et al. J Clin Oncol 2012: 30: 316-321.
15. Anforth R, Tembe V, Blumetti T et al. Pigment Cell Melanoma Res 2012: 25: 569-572.
16. Zimmer L, Hillen U, Livingstone E et al. J Clin Oncol 2012: 30: 2375-2383.
17. Briese T, Paweska J T, McMullan L K et al. PLoS Pathog 2009: 5: e1000455.
18. Palacios G, Druce J, Du L et al. N Engl J Med 2008: 358: 991-998.
19. Feng H, Shuda M, Chang Y et al. Science 2008: 319: 1096-1100.
20. Ganzenmueller T, Yakushko Y, Kluba J et al. Int J Cancer 2012: 131: E1173-E1179.
21. Schowalter R M, Pastrana D V, Pumphrey K A et al. Cell Host Microbe 2010: 7: 509-515.
22. Antonsson A, Forslund O, Ekberg H et al. J Virol 2000: 74: 11636-11641.
23. Feng H, Taylor J L, Benos P V et al. J Virol 2007: 81: 11332-11340.
24. Fagrouch Z, Sarwari R, Lavergne A et al. J Gen Virol 2012: 93: 2652-2657.
25. Arron S T, Ruby J G, Dybbro E et al. J Invest Dermatol 2011: 131: 1745-1753.
26. Kostic A D, Ojesina A I, Pedamallu C S et al. Nat Biotechnol 2011: 29: 393-396.
27. Chen Y E, Tsao H. J Am Acad Dermatol 2013: 69: 143-155.
28. Hanssen I M, Thomma B P. Mol Plant Pathol 2010: 11: 179-189.
29. Fillhart R C, Bachand G D, Castello J D. Appl Environ Microbiol 1998: 64: 1430-1435.
30. Zhang T, Breitbart M, Lee W H et al. PLoS Biol 2006: 4: e3.
31. Rosario K, Nilsson C, Lim Y W et al. Environ Microbiol 2009: 11: 2806-2820.
32. Hatzivassiliou G, Song K, Yen I et al. Nature 2010: 464: 431-435.
33. Flaherty K T, Infante J R, Daud A et al. N Engl J Med 2012: 367: 1694-1703.
34. Siegel D H, McKenzie J, Frieden I J et al. Br J Dermatol 2011: 164: 521-529.
35. Arnault J P, Mateus C, Escudier B et al. Clin Cancer Res 2012: 18: 263-272.
36. Tuttleton Arron S, Jennings L, Nindl I et al. Br J Dermatol 2011: 164: 1201-1213.
37. zur Hausen H. Virology 2009: 384: 260-265.
38. Akgul B, Cooke J C, Storey A. J Pathol 2006: 208: 165-175.
39. Bouwes Bavinck J N, Plasmeijer E I, Feltkamp M C. J Invest Dermatol 2008: 128: 1355-1358.
40. van der Meijden E, Janssens R W, Lauber C et al. PLoS Pathog 2010: 6: 509-515.
41. Falchook G S, Rady P, Hymes S et al. JAMA Dermatol 2013: 149: 322-326.